Short-term cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage

Earnshaw, S., Wilson, M., & Joshi, AV. (2006). Short-term cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Value in Health, 9(3), A8-A8.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Nitric oxide-releasing hemodialysis catheter lock solutions
Article

Matrix matters
Article

Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments